The total return over the past 12 months is -33.96% vs. +16.94% for the S&P 500. So far it's up -36.01% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (33.96%) | (43.09%) | (57.61%) | N/A | N/A | N/A |
| Total Return CAGR | (33.96%) | (43.09%) | (57.61%) | N/A | N/A | N/A |
| Revenue CAGR | +12.79% | (11.50%) | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Bolt Biotherapeutics, Inc. (BOLT)
| Year | Start price | End price | BOLT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.47 | $3.50 | (36.01%) | +14.51% | (50.52%) |
| 2025 | $10.70 | $5.47 | (48.88%) | +17.72% | (66.60%) |
| 2024 | $22.40 | $10.70 | (52.23%) | +24.89% | (77.12%) |
| 2023 | $26.00 | $22.40 | (13.85%) | +26.19% | (40.04%) |
| 2022 | $98.00 | $26.00 | (73.47%) | (18.17%) | (55.30%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
